MyMetabolon Login
© 2021 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Quality Assurance
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Microbiome
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
    • Publications
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
    • Publications
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data
W2017_6-PrecisionMetabolomics

Webinar • Video

Precision Metabolomics: A Single Technology for Understanding Human Health

Metabolon has developed a comprehensive, robust and unbiased way to identify and quantify both endogenous and exogenous metabolites in a biological sample to advance life science research and biomarker discovery. A challenge of this initiative is the fact that a single sample analyzed using a mass spectrometer often produces tens of thousands of data points, but the actual number of metabolites in the same sample is typically only in the couple thousands. This means the majority of data points are actually extraneous (the result of instrument noise, process artifacts and redundant ion features). Sifting through those data points to identify relevant metabolites is a laborious and time-consuming process, fraught with the potential for “false positives.”

To overcome this challenge, Metabolon embraces a chemo-centric approach that rapidly and efficiently removes noise and identifies metabolites. Our Precision Metabolomics™ technology automatically compares the generated data against our extensive chemical library to isolate relevant metabolites in a matter of minutes. The result is accurate, reproducible and actionable data that provides a snapshot of health. In the webinar, we also share applications of this technology in precision medicine.

Watch the Video
Back to Resource Library
  • Leveraging the Metabolome for Answers with Metabolomics Technology
    Previous ProjectLeveraging the Metabolome for Answers with Metabolomics Technology
  • Next ProjectA Targeted Approach to Metabolomics
    Leveraging the Metabolome for Answers with Metabolomics Technology

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Quality Assurance
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events
  • Publications

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2022 Metabolon, Inc. All rights reserved. Privacy & Terms

in
Copy